Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yoshimura

Showing results (351-360 of 362) with videos related to

Pageof 37
Sort By:
Nature|June 26, 1997
A new protein containing an SH2 domain that inhibits JAK kinasesT A Endo, M Masuhara, M Yokouchi, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|November 1, 1981
[The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)]T Wakasugi, T Sakai, A Watanabe, et al.
Nihon Ika Daigaku Zasshi|January 20, 1999
[A case of adenocarcinoma of the lung presenting ground glass opacity detected by spiral CT in lung cancer screening]K Yamamoto, M Andoh, K Uematsu, et al.
ESMO Open|February 17, 2026
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancerY Katayama, A Fukuda, R Inoue, et al.
Journal of Dental Research|September 29, 2012
Assessment of the plasma/serum IgG test to screen for periodontitisC Kudo, K Naruishi, H Maeda, et al.
ESMO Open|July 27, 2025
Effectiveness of post-trastuzumab deruxtecan treatments and incidence of interstitial lung disease in HER2-positive metastatic breast cancer: a real-world, observational cohort studyK Nozawa, H Iwata, T Mukohara, et al.
Science Immunology|October 8, 2021
Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skinH Takahashi, H Nomura, H Iriki, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progressionK Morimoto, T Yamada, N Furuya, et al.
Clinical Genetics|March 1, 2017
Clinical and mutational spectrum of Japanese patients with Charcot-Marie-Tooth disease caused by GDAP1 variantsA Yoshimura, J-H Yuan, A Hashiguchi, et al.
Japanese Journal of Clinical Oncology|December 5, 1998
Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in JapanS Egawa, H Futami, K Takasaki, et al.
Pageof 37

Showing results (351-360 of 362) with videos related to

Sort By:
Pageof 37
Nature|June 26, 1997
A new protein containing an SH2 domain that inhibits JAK kinasesT A Endo, M Masuhara, M Yokouchi, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|November 1, 1981
[The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)]T Wakasugi, T Sakai, A Watanabe, et al.
Nihon Ika Daigaku Zasshi|January 20, 1999
[A case of adenocarcinoma of the lung presenting ground glass opacity detected by spiral CT in lung cancer screening]K Yamamoto, M Andoh, K Uematsu, et al.
ESMO Open|February 17, 2026
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancerY Katayama, A Fukuda, R Inoue, et al.
Journal of Dental Research|September 29, 2012
Assessment of the plasma/serum IgG test to screen for periodontitisC Kudo, K Naruishi, H Maeda, et al.
ESMO Open|July 27, 2025
Effectiveness of post-trastuzumab deruxtecan treatments and incidence of interstitial lung disease in HER2-positive metastatic breast cancer: a real-world, observational cohort studyK Nozawa, H Iwata, T Mukohara, et al.
Science Immunology|October 8, 2021
Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skinH Takahashi, H Nomura, H Iriki, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progressionK Morimoto, T Yamada, N Furuya, et al.
Clinical Genetics|March 1, 2017
Clinical and mutational spectrum of Japanese patients with Charcot-Marie-Tooth disease caused by GDAP1 variantsA Yoshimura, J-H Yuan, A Hashiguchi, et al.
Japanese Journal of Clinical Oncology|December 5, 1998
Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in JapanS Egawa, H Futami, K Takasaki, et al.
Pageof 37